The Veterinary Contract Research Organization Market Report is Segmented by Service Type (Clinical Trials, Toxicology, Regulatory & Consulting, Other Specialized Services), Animal Type (Companion Animals, Livestock), End User (Animal-Health Pharma & Biotech Companies, Academic & Research Institutes, Other End Users), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Veterinary CRO Market size was valued at USD 1.56 Billion in 2023 and is projected to reach USD 2.13 Billion by 2030, growing at a CAGR of 8.1% from 2024 to 2030.

Global Veterinary CRO Market Drivers

Increasing Demand for Veterinary pharmaceuticals and therapies: Veterinary pharmaceuticals, biologics, and therapies are in high demand due to the world's expanding pet population as well as the growing emphasis on animal health and welfare. Veterinary CROs are vital to the development and testing of these medicines because they offer preclinical and clinical research services, which propel the market's expansion.

Developments in Veterinary Medicine: The field is seeing rapid advancements in regenerative therapies, personalized medicine, and genomics, which is driving up demand for specialist research and development skills. Veterinary CROs help pharmaceutical and biotechnology businesses to discover and launch novel veterinary treatments by providing expertise in areas including pharmacokinetics, toxicity, and efficacy studies.

The size of the Veterinary CRO Industry market was valued at USD 0.92 Million in 2023 and is projected to reach USD 1.60 Million by 2032, with an expected CAGR of 8.27% during the forecast period. Recent developments include: In April 2022, PetDx funded a clinical trial under the title , 'Clinical validation of a next-generation sequencing-based multi-cancer early detection 'liquid biopsy' blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study'. The goal of this clinical trial was to test the performance of a new multi-cancer blood test in detecting and characterizing cancer in dogs., In January 2022, Covetrus, a global leader in animal health technology and services, announced the launch of Covetrus Pulse, an innovative cloud-based veterinary operating system (vOS) that easily connects veterinarians to the technology they need to manage their practices and allows more time to spend with the animals in their care.. Key drivers for this market are: Growing Burden of Diseases in Animals, Increasing Expenditure on Research and Development Activities. Potential restraints include: Lack of Skilled Professionals. Notable trends are: Clinical Trial Support​ Segment is Expected to Hold a Major Market Share in the Veterinary CRO Market.

The Veterinary CRO Market will grow from USD 1.62 Billion in 2024 to USD 2.65 Billion by 2030 at a 8.53% CAGR.

Check Market Research Intellect's Veterinary CRO Market Report, pegged at USD 4.5 billion in 2024 and projected to reach USD 7.2 billion by 2033, advancing with a CAGR of 6.5% (2026-2033).Explore factors such as rising applications, technological shifts, and industry leaders.

According to Cognitive Market Research, the global Veterinary CRO Market size will be USD 1692.4 million in 2025. It will expand at a compound annual growth rate (CAGR) of 8.70% from 2025 to 2033.

North America held the major market share for more than 37% of the global revenue with a market size of USD 626.19 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2033.
Europe accounted for a market share of over 29% of the global revenue with a market size of USD 490.80 million.
APAC held a market share of around 24% of the global revenue with a market size of USD 406.18 million in 2025 and will grow at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2033.
South America has a market share of more than 4% of the global revenue with a market size of USD 64.31 million in 2025 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2033.
Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 67.70 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2033.
Africa had a market share of around 2.2% of the global revenue and was estimated at a market size of USD 37.23 million in 2025 and will grow at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2033.
Toxicology category is the fastest growing segment of the Veterinary CRO Market

Market Dynamics of Veterinary CRO Market

Key Drivers for Veterinary CRO Market

Increasing Pet Ownership and Humanization

The growing trend of pet ownership, especially among millennials and Gen Z, has led to a significant rise in the demand for veterinary services. Pet owners are increasingly treating their pets as family members, which has driven the need for advanced veterinary care, diagnostics, and treatment options. This humanization of pets, coupled with rising awareness about pet health, has spurred the demand for high-quality veterinary pharmaceuticals and medical devices. For example, the American Pet Products Association (APPA) reported that pet ownership in the U.S. reached an all-time high, with 70% of households owning a pet as of 2021. This trend is increasingly seen in younger generations, like Millennials and Gen Z, who are more likely to spend on pet health care. Thus, Veterinary CROs are seeing an uptick in business, as pet owners seek more advanced and personalized medical treatments for their animals. This trend is expected to continue growing, further propelling the market for veterinary research services and fostering investments in innovative treatment development.

https://americanpetproducts.org/industry-trends-and-statsIntegration of Digital Health Technologies

Digital health technologies, such as telemedicine, electronic health records (EHRs), and diagnostic software, are revolutionizing veterinary care. These advancements have significantly impacted the efficiency of clinical trials, data collection, and animal health monitoring. By adopting these digital tools, Veterinary CROs can improve data accuracy, streamline operations, and enhance collaboration with researchers and pharmaceutical companies. Additionally, digital health technologies enable real-time monitoring of animals in clinical trials, improving the quality and speed of studies. This shift towards digital transformation is making veterinary research more accessible and cost-effective, benefiting both small and large enterprises involved in veterinary medicine. The growing acceptance of these technologies among veterinary professionals is expected to boost the CRO market.

Restraint Factor for the Veterinary CRO Market

High Research and Development Costs

Veterinary research and development (R&D) are costly, particularly when it comes to clinical trials, drug testing, and regulatory approvals. Developing veterinary pharmaceuticals, biologics, or vaccines requires significant investments in lab equipment, skilled personnel, and extensive clinical trials. The cost burden can be particularly heavy for small or mid-sized companies, limiting their ability to fund the R&D necessary to bring new products to market. Additionally, some animal health products face high levels of scrutiny, further elevating the cost of development. While larger companies may absorb these costs, the high expenses of veterinary R&D may be a significant challenge for new entrants or smaller research organizatio...

The Veterinary CRO and CDMO Market Report is Segmented by Animal Type (Companion Animals, Livestock Animals), Services (Discovery, Development, Manufacturing, Packaging & Labelling, Market Approval & Post-Marketing), Application (Medicines, Medical Devices), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

The veterinary CRO market is booming, projected to reach $7 billion by 2033 with a 12% CAGR. Discover key drivers, trends, and leading companies shaping this rapidly expanding sector. Explore market size, regional analysis, and future growth projections in our comprehensive report.

Snapshot img

Veterinary CRO Market Size 2024-2028

The veterinary CRO market size is forecast to increase by USD 200.8 million at a CAGR of 5.8% between 2023 and 2028.

The veterinary CRO market is experiencing significant growth due to several key drivers. The rise in pet ownership and the subsequent increase in the diseased population among companion animals are primary factors fueling market expansion. Strict government regulations, particularly in relation to animal seizures and the ethical treatment of animals in clinical trials, are also influencing market trends.
Moreover, outsourcing of veterinary research to contract research organizations (CROs) and the advancement of clinical trials in various phases, including oncology trials for dogs, further contribute to market growth. The human resource access required for the development and production of veterinary drugs is another critical factor driving market development. Overall, the veterinary drugs industry is witnessing substantial growth and innovation, with a focus on improving animal health and welfare.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The veterinary clinical research and development (CRO) market plays a crucial role in advancing the field of veterinary medicine. This sector focuses on ensuring the safety, efficacy, and regulatory compliance of veterinary drugs and treatments. Animal health economics is a significant consideration within the market. Veterinary drug trials are conducted to assess the safety, efficacy, and optimal dosing of new treatments. These trials adhere to strict animal health policies and regulations to ensure the welfare of the animals involved. Veterinary data processing is an integral part of the clinical research process.
Moreover, it involves collecting, analyzing, and interpreting data from various sources, including PK/PD studies and tolerance studies, to inform veterinary treatment plans and improve animal health innovation. Animal diseases pose a constant threat to animal populations and require ongoing research and development. Veterinary medicine technology, including veterinary toxicology, is essential in identifying and addressing these diseases. Ethical considerations, such as veterinary research ethics, are paramount in ensuring the humane treatment of animals during research. Animal health development is a collaborative effort between veterinary CROs, researchers, and policymakers. Animal health regulations and legislation are crucial in ensuring the safety and efficacy of veterinary treatments.
Pet travel and pet ownership are growing trends, leading to an increased demand for veterinary care. Pet medication online and pet health insurance are becoming more accessible, making veterinary marketing and education essential components of the market. Animal behavior and welfare are also important areas of research within the market. Animal training, animal shelters, and animal rights are all topics that require ongoing research and innovation to improve the lives of animals. Pet care tips and pet health insurance are essential services for pet owners. Veterinary legislation and pet grooming are important considerations for pet owners and veterinary professionals alike.
In conclusion, the veterinary clinical research and development market plays a vital role in advancing the field of veterinary medicine. It is essential in ensuring the safety, efficacy, and regulatory compliance of veterinary treatments, while also addressing the ongoing needs of animal health and welfare.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Clinical trials
  Toxicology
  Market authorization and regulatory support


Geography

  North America

    Canada
    Mexico
    US


  Europe

    Germany
    UK
    France
    Spain


  Asia

    China
    India
    Japan


  Rest of World (ROW)

By Type Insights

The clinical trials segment is estimated to witness significant growth during the forecast period.

The veterinary Contract Research Organizations (CRO) market plays a significant role in the advancement of animal healthcare through outsourcing clinical trials. These trials are essential for investigating new treatments and therapies for various animal diseases. The clinical trials segment is the largest sector in the market. Animal clinical trials encompass a wide range of research areas, including the development of new medications, diagnostic methods, surgical procedures, and equipment. These trials can improve the quality of life for dogs, particularly those with chronic illnesses, by offering innovative treatments and solutions. The initiation of a v

The global veterinary CRO & CDMO market size was worth around USD 7.14 billion in 2024 and is predicted to grow to around USD 15.99 billion by 2034

The global veterinary contract research organization (CRO) market, valued at $0.92 billion in 2025, is experiencing robust growth, projected to expand at a compound annual growth rate (CAGR) of 8.27% from 2025 to 2033. This expansion is fueled by several key factors. The increasing prevalence of zoonotic diseases necessitates rigorous research and development of novel veterinary therapeutics and diagnostics, driving demand for CRO services. Furthermore, the rising pet ownership globally, coupled with increasing pet healthcare expenditure, contributes significantly to market growth. Technological advancements in veterinary research, particularly in areas like genomics and bioinformatics, also enhance the efficiency and accuracy of CRO services, further stimulating market expansion. The market is segmented by service type, with clinical trials support and quality assurance representing the major segments. Key players such as Charles River Laboratories, Clinvet, and others are actively involved, competing through service diversification and strategic partnerships. Geographic expansion, especially in emerging economies with rising veterinary infrastructure, presents lucrative opportunities for growth. Regulatory changes and increasing emphasis on data integrity are anticipated to shape industry dynamics in the coming years. The North American region currently dominates the market, driven by strong regulatory frameworks and a high concentration of veterinary research facilities. However, the Asia-Pacific region is expected to exhibit significant growth potential due to expanding economies and rising pet ownership in countries like China and India. Europe will continue to be a significant market, driven by robust research and development spending and a highly developed veterinary healthcare system. The competitive landscape is marked by a mix of large multinational CROs and smaller specialized firms. Successful companies are differentiating themselves through specialized expertise, advanced technologies, and a strong focus on client relationships. Future growth will be influenced by factors like technological innovations, evolving regulatory landscapes, and the ongoing need for effective and safe veterinary medicines and diagnostics. Recent developments include: In April 2022, PetDx funded a clinical trial under the title , 'Clinical validation of a next-generation sequencing-based multi-cancer early detection 'liquid biopsy' blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study'. The goal of this clinical trial was to test the performance of a new multi-cancer blood test in detecting and characterizing cancer in dogs., In January 2022, Covetrus, a global leader in animal health technology and services, announced the launch of Covetrus Pulse, an innovative cloud-based veterinary operating system (vOS) that easily connects veterinarians to the technology they need to manage their practices and allows more time to spend with the animals in their care.. Key drivers for this market are: Growing Burden of Diseases in Animals, Increasing Expenditure on Research and Development Activities. Potential restraints include: Growing Burden of Diseases in Animals, Increasing Expenditure on Research and Development Activities. Notable trends are: Clinical Trial Support​ Segment is Expected to Hold a Major Market Share in the Veterinary CRO Market.

The size of the Veterinary CRO Market was valued at USD 616.62 million in 2024 and is projected to reach USD 914.99 million by 2033, with an expected CAGR of 5.8% during the forecast period.

The size of the Veterinary CRO market was valued at USD XXX million in 2024 and is projected to reach USD XXX million by 2033, with an expected CAGR of XX% during the forecast period.

The size of the Veterinary CRO And CDMO Market was valued at USD 6.34 Million in 2023 and is projected to reach USD 11.01 Million by 2032, with an expected CAGR of 8.20% during the forecast period. The Veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is experiencing significant growth, driven by increasing demand for animal health solutions and innovations in veterinary medicine. Veterinary CROs provide outsourced research services to pharmaceutical and biotech companies, focusing on preclinical and clinical trials, regulatory support, and post-approval studies. Simultaneously, CDMOs offer services for the development and manufacturing of veterinary drugs, vaccines, and nutraceuticals. The rise in pet ownership, livestock farming, and awareness about zoonotic diseases has fueled the demand for advanced veterinary products, prompting pharmaceutical companies to seek specialized outsourcing partners to streamline drug development and production. The market is further propelled by technological advancements such as precision medicine, biologics, and digital tools for trial management. Recent developments include: July 2023: Argenta announced a new strategic enterprise partnership. This partnership was established to provide an eClinical technology partner and help bring fresh ideas and technology to meet these innovation objectives., June 2023: Transpharmation Canada Ltd and Veterinary Health Research Centers LLC (VHRC), a niche CRO, announced their strategic co-marketing partnership at the Animal Health, Nutrition & Technology Innovation USA Conference. This collaboration will enable a seamless transition of preclinical work conducted by Transpharmation into Proof of Concept or pre-IND/INAD clinical trials using animals with real-world conditions traditionally unavailable in research colonies.. Key drivers for this market are: Wide Adoption of Veterinary Outsourcing Services, Increasing Demand for Animal Health Products; Rising Spending on Development and Research. Potential restraints include: Lack of Standardization in Veterinary CRO, Regulatory Challenges and High Initial Investment Costs.

The global veterinary CRO and CDMO market is set to witness a growth rate of 9% in the next 5 years. Rapid growth in companion-animal healthcare spending, rise of complex modalities, growing pressure to shorten time-to-market & control R&D costs, and growing consolidation & preference for platform service models, are some of the key factors […]

The booming Veterinary CRO & CDMO market, valued at $6.34B in 2025, is projected to grow at an 8.20% CAGR through 2033. Discover key market trends, leading companies, and regional insights in this comprehensive analysis of veterinary drug development and manufacturing. Recent developments include: July 2023: Argenta announced a new strategic enterprise partnership. This partnership was established to provide an eClinical technology partner and help bring fresh ideas and technology to meet these innovation objectives., June 2023: Transpharmation Canada Ltd and Veterinary Health Research Centers LLC (VHRC), a niche CRO, announced their strategic co-marketing partnership at the Animal Health, Nutrition & Technology Innovation USA Conference. This collaboration will enable a seamless transition of preclinical work conducted by Transpharmation into Proof of Concept or pre-IND/INAD clinical trials using animals with real-world conditions traditionally unavailable in research colonies.. Key drivers for this market are: Wide Adoption of Veterinary Outsourcing Services, Increasing Demand for Animal Health Products; Rising Spending on Development and Research. Potential restraints include: Wide Adoption of Veterinary Outsourcing Services, Increasing Demand for Animal Health Products; Rising Spending on Development and Research. Notable trends are: The Companion Animal Segment is Expected to Hold a Significant Market Share Between 2024 and 2029.

The North America Veterinary CRO and CDMO report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights into capital flows and market shifts, guiding investors toward growth opportunities in key industry segments and regions.

Market Research Intellect presents the Veterinary CRO And CDMO Market Report-estimated at USD 4.5 billion in 2024 and predicted to grow to USD 7.8 billion by 2033, with a CAGR of 7.5% over the forecast period. Gain clarity on regional performance, future innovations, and major players worldwide.

The booming Veterinary CRO & CDMO market is projected to reach $5.97 billion by 2025, growing at an 8.4% CAGR. Learn about key drivers, trends, and leading companies shaping this dynamic sector. Discover market size forecasts and regional analysis for informed business decisions.

Animal Health CRO Services Market Outlook

According to our latest research, the global Animal Health CRO Services market size reached USD 1.65 billion in 2024, demonstrating robust expansion driven by increasing R&D investments and a surging demand for veterinary therapeutics. The market is forecasted to grow at a CAGR of 8.2% from 2025 to 2033, reaching an estimated USD 3.22 billion by 2033. This impressive growth trajectory is fueled by the rising prevalence of zoonotic diseases, rapid advancements in veterinary medicine, and an increasing trend toward outsourcing research activities to specialized contract research organizations (CROs) to optimize costs and accelerate time-to-market for animal health products.

One of the primary growth drivers for the Animal Health CRO Services market is the escalating focus on animal welfare and the rising incidence of infectious and chronic diseases among both livestock and companion animals. The growing humanization of pets, coupled with increasing awareness about animal health and preventive care, has led to a surge in demand for innovative veterinary pharmaceuticals and biologics. This, in turn, has compelled pharmaceutical and biotechnology companies to ramp up their research and development pipelines, subsequently increasing the reliance on specialized CROs for preclinical and clinical research services. Moreover, the globalization of the animal health sector has necessitated adherence to stringent regulatory frameworks, further boosting the need for expert CRO partners who can navigate complex regulatory landscapes efficiently.

Another significant growth factor is the technological advancements that have transformed the landscape of animal health research. The integration of digital technologies, artificial intelligence, and big data analytics into clinical trial design and execution has enabled CROs to offer more precise and efficient research services. These advancements have not only improved the accuracy of data collection and analysis but have also reduced the time and costs associated with drug development. The adoption of advanced technologies by CROs has made them indispensable partners for animal health companies seeking to expedite product development while maintaining compliance with global regulatory standards. This technological evolution is expected to further propel the growth of the Animal Health CRO Services market in the coming years.

Furthermore, the increasing trend of strategic collaborations and partnerships between animal health companies and CROs is playing a pivotal role in market expansion. Pharmaceutical and biotechnology firms are increasingly outsourcing their R&D activities to CROs to gain access to specialized expertise, state-of-the-art infrastructure, and global reach. This outsourcing model enables companies to focus on their core competencies while leveraging the CROs’ capabilities to achieve faster and more cost-effective product development. The growing complexity of veterinary drug development, coupled with the need for multidisciplinary approaches, is expected to drive the demand for comprehensive CRO services across the animal health industry.

From a regional perspective, North America continues to dominate the Animal Health CRO Services market, accounting for the largest share in 2024, followed by Europe and Asia Pacific. The presence of major pharmaceutical and biotechnology companies, a well-established regulatory framework, and high investments in animal health research contribute to North America’s leading position. However, the Asia Pacific region is witnessing the fastest growth, driven by increasing livestock production, rising pet adoption rates, and growing investments in veterinary healthcare infrastructure. The market in Europe remains robust, supported by a strong focus on animal welfare and a high level of research activity in the region. Latin America and the Middle East & Africa, while currently representing smaller market shares, are expected to offer significant growth opportunities due to evolving animal health standards and increasing government initiatives.